agilon health (AGL) The 44th Annual William Blair Growth Stock Conference summary
Event summary combining transcript, slides, and related documents.
The 44th Annual William Blair Growth Stock Conference summary
1 Feb, 2026Macro context and industry trends
Demand for alternatives to fee-for-service in primary care is at an all-time high, driven by physician burnout and unsustainable economics.
Structural support from policymakers and payers is accelerating the shift to value-based care.
Market volatility and increased Medicare Advantage utilization are creating both challenges and opportunities for growth.
The company’s model is positioned as a solution to variability and inefficiency in primary care delivery.
Business model and operational performance
The Total Care Model enables primary care doctors to manage Medicare risk, improving access, quality, and cost outcomes.
Demonstrated two to three times increase in annual wellness visits and quality scores above CMS thresholds.
Significant reductions in hospitalizations, ER visits, and readmissions among senior patients.
Peer-reviewed study showed a 65% reduction in hospital-based deaths and 33% lower total cost of care for palliative patients.
Growth, financial drivers, and action plan
Operating in 30 markets with 2,400 PCPs and 635,000 senior patients, with strong membership and partner growth.
ACO REACH business outperformed national benchmarks by 320 basis points in 2023.
Mature member cohorts sustain attractive medical margins (~$150 PMPM), with newer cohorts showing positive progression.
Ongoing action plan focuses on PCP support, payer partnerships, data integration, and operating efficiency.
Latest events from agilon health
- Shareholders approved a reverse stock split and adjournment proposal, both backed by the Board.AGL
EGM 202617 Mar 2026 - Transformation, data-driven care, and disciplined contracting set the stage for growth and stability.AGL
Barclays 28th Annual Global Healthcare Conference10 Mar 2026 - Disciplined contracting, cost controls, and clinical programs drive margin gains amid elevated trends.AGL
TD Cowen 46th Annual Health Care Conference2 Mar 2026 - 2025 losses and lower membership set up for breakeven EBITDA and margin gains in 2026.AGL
Q4 202525 Feb 2026 - Stockholders to vote on a reverse stock split, reducing shares to as low as 16.6 million.AGL
Proxy Filing20 Feb 2026 - Virtual vote on reverse stock split and adjournment proposal to maintain NYSE compliance.AGL
Proxy Filing18 Feb 2026 - Shareholders to vote on a reverse stock split and possible adjournment, with board discretion on implementation.AGL
Proxy Filing6 Feb 2026 - Q2 revenue up 39% to $1.5B, but net loss widened and margins declined on higher costs.AGL
Q2 20242 Feb 2026 - Cost trends are improving, membership is growing, and clinical initiatives are reducing utilization.AGL
2024 Wells Fargo Healthcare Conference22 Jan 2026